'Effects of risperidone augmentation in patients with treatment-resistant depression: results of open-label treatment followed by double-blind continuation'.
Carroll
Bernard J
BJ
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D002986:Clinical Trials as Topic / Q000941:ethics / Q000592:standards*; D016265:Conflict of Interest / Q000191:economics*; D003627:Data Interpretation, Statistical; D003866:Depressive Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D004351:Drug Resistance / Q000187:drug effects; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D015203:Reproducibility of Results; D012180:Retraction of Publication as Topic; D018570:Risk Assessment / Q000941:ethics / Q000379:methods; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects*; D055502:Secondary Prevention; D015430:Weight Gain / Q000187:drug effects
D014150:Antipsychotic Agents; D018967:Risperidone